Quantum Pharma PLC Notification of Major Interest in Shares (1731V)
October 31 2017 - 2:01PM
UK Regulatory
TIDMQP. TIDM84JL
RNS Number : 1731V
Quantum Pharma PLC
31 October 2017
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible)
---------------------------------------------------------------------------------------------------------
1a. Identity of the issuer or the QUANTUM PHARMA PLC
underlying issuer of existing shares
to which voting rights are attached:
----------------------------------------------------------- --------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
---------------------------------------------------------------------------------------------------------
UK issuer X
--------------------------------------------------------------------------------------------------- ----
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
---------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
--------------------------------------------------------------------------------------------------- ----
An acquisition or disposal of financial instruments
--------------------------------------------------------------------------------------------------- ----
An event changing the breakdown of voting rights
--------------------------------------------------------------------------------------------------- ----
Other (please specify):
--------------------------------------------------------------------------------------------------- ----
3. Details of person subject to the notification obligation
Name Bank of America Corporation
City and country of registered office Wilmington, DE, United States
(if applicable)
4. Full name of shareholder(s) (if different from 3.)
---------------------------------------------------------------------------------------------------------
Name Merrill Lynch International
----------------------------------------------------------- --------------------------------------------
City and country of registered office London, United Kingdom
(if applicable)
----------------------------------------------------------- --------------------------------------------
5. Date on which the threshold was 27(th) October 2017
crossed or reached:
----------------------------------------------------------- --------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 31(th) October 2017
----------------------------------------------------------- --------------------------------------------
7. Total positions of person(s) subject to the notification obligation
---------------------------------------------------------------------------------------------------------
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer
of 8. A) (total of 8.B
1 + 8.B 2)
------------------------ ------------------ --------------------- -------------- --------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 13.370% 0.000% 13.370% 169,117,640
------------------------ ------------------ --------------------- -------------- --------------------
Position of
previous notification
(if
applicable) 12.844% 0.000% 12.844%
------------------------ ------------------ --------------------- -------------- --------------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached
-----------------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
-----------------------------------------------------------------------------------------------------------------------------------
Class/type of Number of voting rights % of voting rights
shares
ISIN code (if
possible)
------------------
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) Directive
(DTR5.1) (DTR5.2.1) 2004/109/EC)
(DTR5.2.1)
------------ ---- ------------------------- ------------------------------ ------------------------------ --------------------
GB00BRTL8Q42 0 22,611,221 0.000% 13.370%
------------------ ------------------------- ------------------------------ ------------------------------ --------------------
SUBTOTAL 8. A 22,611,221 13.370%
------------------ --------------------------------------------------------- ----------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive
2004/109/EC (DTR5.3.1.1 (a))
-----------------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may rights
be acquired if
the instrument
is
exercised/converted.
------------------ ------------- ---------------------------------- -------------------------------------- --------------------
N/A
------------------ ------------- ---------------------------------- -------------------------------------- --------------------
SUBTOTAL 8. B 1
---------------------------------- -------------------------------------- --------------------
B 2: Financial Instruments with similar economic effect according to
Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
-----------------------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Physical or Number of % of voting
financial date Conversion cash voting rights rights
instrument Period settlement
------------ ------------------- ------------------- ---------------------------- ----------------------- --------------------
N/A
------------ ------------------- ------------------- ---------------------------- ----------------------- --------------------
SUBTOTAL 8.B.2
---------------------------- ----------------------- --------------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any
other undertaking(s) holding directly or indirectly an interest
in the (underlying) issuer
Full chain of controlled undertakings through which the voting X
rights and/or the
financial instruments are effectively held starting with the
ultimate controlling natural person or legal entity (please add
additional rows as necessary)
---------------------------------------------------------------------------------------------------------------------------- -----
Name % of voting rights % of voting rights Total of both
if it equals through financial if it equals
or is higher instruments if or is higher
than the notifiable it equals or is than the notifiable
threshold higher than the threshold
notifiable threshold
----------------------------------- -------------------------------- --------------------------------- -------------------------
Bank of America Corporation N/A N/A N/A
----------------------------------- -------------------------------- --------------------------------- -------------------------
NB Holdings Corporation N/A N/A N/A
----------------------------------- -------------------------------- --------------------------------- -------------------------
Merrill Lynch International N/A N/A N/A
Incorporated
----------------------------------- -------------------------------- --------------------------------- -------------------------
BofAML Jersey Holdings N/A N/A N/A
Limited
----------------------------------- -------------------------------- --------------------------------- -------------------------
BofAML EMEA Holdings 1 N/A N/A N/A
Limited
----------------------------------- -------------------------------- --------------------------------- -------------------------
BofAML EMEA Holdings 2 N/A N/A N/A
Limited
----------------------------------- -------------------------------- --------------------------------- -------------------------
ML UK Capital Holdings N/A N/A N/A
Limited
----------------------------------- -------------------------------- --------------------------------- -------------------------
Merrill Lynch International 13.370% N/A 13.370%
----------------------------------- -------------------------------- --------------------------------- -------------------------
10. In case of proxy voting, please identify:
-----------------------------------------------------------------------------------------------------------------------------------
Name of the proxy holder
------------------------------------------------------------- --------------------------------------------------------------------
The number and % of voting rights
held
------------------------------------------------------------- --------------------------------------------------------------------
The date until which the voting rights
will be held
------------------------------------------------------------- --------------------------------------------------------------------
11. Additional information
-----------------------------------------------------------------------------------------------------------------------------------
Place of completion United Kingdom
-------------------- --------------------
Date of completion 31(th) October 2017
-------------------- --------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLWGGPCUUPMGMG
(END) Dow Jones Newswires
October 31, 2017 14:01 ET (18:01 GMT)
Quantum Phar. (LSE:QP.)
Historical Stock Chart
From Oct 2024 to Nov 2024
Quantum Phar. (LSE:QP.)
Historical Stock Chart
From Nov 2023 to Nov 2024
